| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/05/2001 | US6242461 Use of aryl substituted azabenzimidazoles in the treatment of HIV and AIDS related diseases |
| 06/05/2001 | US6242458 Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| 06/05/2001 | US6242457 Oxime derivatives |
| 06/05/2001 | US6242438 3-Azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
| 06/05/2001 | US6242434 Treatment and prophylaxis of hyperparathyroidism and hyperproliferative diseases, and in the modulation of the immune and inflammatory responses as well as the treatment of bone depletive disorders. |
| 06/05/2001 | US6242428 Nucleosides and nucleoside dimers containing an l-sugar in at least one of the nucleosides |
| 06/05/2001 | US6242419 Genes encoding proteins expressed in lymph node stromal cells from flaky skin (fsn-/-) mice and their use in therapy. |
| 06/05/2001 | US6242255 Protein which induces interferon-gamma production by immunocompetent cell |
| 06/05/2001 | US6242238 Nucleotide sequence which codes for heparinase; drug screening for antimetastasis/antinflammatory agents, angiogenesis inhibitors, wound healing agents; treatment for angioplasty-induced restenosis and atherosclerosis |
| 06/05/2001 | US6242212 Nucleotide sequences which code a protein for the diagnosis, detection and treatment of cancer |
| 06/05/2001 | US6242203 Tumor-specific P450 protein |
| 06/05/2001 | US6242201 Detection of protein that preferentially binds to proliferating cells; for the treatment of psoriasis, cancer and cell proliferative defect |
| 06/05/2001 | US6242179 Nucleotide sequences coding eukaryotic hydrolase; for the diagnosis, prevention, and treatment of immune defects and cancers; anticarcinogenic agents |
| 06/05/2001 | US6241985 Method and composition for reconforming multi-epitopic antigens to initiate an immune response |
| 06/05/2001 | US6241982 Method for treating brain cancer with a conditionally lethal gene |
| 06/05/2001 | US6241961 Administering to bone marrow of patient a dose of a monoclonal antibody or antibody fragment stably coupled to a cadmium-66 radioisotope; side effect reduction |
| 06/05/2001 | CA2216291C Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 06/05/2001 | CA2216163C Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 06/05/2001 | CA1341241C Expression of a tumor-specific antigen through a recombinant virus vector, and its use for prevention or cure of the corresponding tumor |
| 06/03/2001 | CA2327385A1 Sulfamoylheteroaryl pyrazole compounds as anti-inflammatory/analgesic agents |
| 06/03/2001 | CA2327256A1 Heteroaryl phenyl pyrazole compounds as anti-inflammatory/analgesic agents |
| 06/01/2001 | CA2327140A1 Novel protein conjugates and process for the preparation thereof |
| 05/31/2001 | WO2001038878A2 Pin1 as a marker for abnormal cell growth |
| 05/31/2001 | WO2001038566A2 Screening method for candidate drugs |
| 05/31/2001 | WO2001038552A2 Excipient system that contains coating substances with enzymatically removable side-groups |
| 05/31/2001 | WO2001038548A2 Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors |
| 05/31/2001 | WO2001038532A2 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
| 05/31/2001 | WO2001038503A2 Novel human protein kinases and protein kinase-like enzymes |
| 05/31/2001 | WO2001038496A1 A human normal counterpart of cd4+ cd56+ cutaneous neoplasm |
| 05/31/2001 | WO2001038494A1 Method of proliferating natural killer cells |
| 05/31/2001 | WO2001038490A2 ISOLATION OF FIVE NOVEL GENES CODING FOR NEW Fc RECEPTORS-TYPE MELANOMA INVOLVED IN THE PATHOGENESIS OF LYMPHOMA/MELANOMA |
| 05/31/2001 | WO2001038486A2 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 05/31/2001 | WO2001038397A1 N-alkylated peptides having antiangiogenic activity |
| 05/31/2001 | WO2001038393A1 Polypeptides derived from vitamin d nuclear receptor, and their uses in particular for screening vitamin d analogues |
| 05/31/2001 | WO2001038392A1 Novel transcription factor and dna thereof |
| 05/31/2001 | WO2001038389A1 A new polypeptide-ribosomal protein l14.22 and the polynucleotide encoding it |
| 05/31/2001 | WO2001038385A1 A new polypeptide-human phosphatase 79 and the polynucleotide encoding it |
| 05/31/2001 | WO2001038379A1 A new polypeptide-human ribosomal protein l23 and the polynucleotide encoding it |
| 05/31/2001 | WO2001038378A1 A new polypeptide-zinc finger protein 69 and the polynucleotide encoding it |
| 05/31/2001 | WO2001038376A1 A new polypeptide-zinc finger protein 46 and the polynucleotide encoding it |
| 05/31/2001 | WO2001038375A1 A new polypeptide-zinc finger protein 58 and the polynucleotide encoding it |
| 05/31/2001 | WO2001038374A1 Tumour suppressor factor |
| 05/31/2001 | WO2001038361A1 Modified adenovirus fibre and uses |
| 05/31/2001 | WO2001038352A2 Methods of inhibiting metastasis |
| 05/31/2001 | WO2001038347A2 Peptides having antiangiogenic activity |
| 05/31/2001 | WO2001038344A2 Modulation of signal transduction |
| 05/31/2001 | WO2001038339A1 Antimitotic compounds |
| 05/31/2001 | WO2001038325A1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 05/31/2001 | WO2001038324A2 Imidazole derivatives and their use as raf kinase inhibitors |
| 05/31/2001 | WO2001038323A1 Pyrazinone thrombin inhibitors |
| 05/31/2001 | WO2001038322A1 Inhibitors of histone deacetylase |
| 05/31/2001 | WO2001038320A1 Vitamin d analogues |
| 05/31/2001 | WO2001038318A1 Cytotoxic agents comprising taxanes and their therapeutic use |
| 05/31/2001 | WO2001038315A1 Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes |
| 05/31/2001 | WO2001038314A1 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors |
| 05/31/2001 | WO2001038313A1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p39 kINASE INHIBITORS |
| 05/31/2001 | WO2001038312A1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p38 KINASE INHIBITORS |
| 05/31/2001 | WO2001038311A2 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 05/31/2001 | WO2001038305A2 Novel il-8 receptor antagonists |
| 05/31/2001 | WO2001038303A2 Vitamin d analogues |
| 05/31/2001 | WO2001038295A1 Sphingosine derivatives |
| 05/31/2001 | WO2001037877A1 Remedies for diseases in association with decrease in bone mass |
| 05/31/2001 | WO2001037868A1 Assays and therapies for latent viral infection |
| 05/31/2001 | WO2001037866A1 A method of treating a malignancy in a subject and a pharmaceutical composition for use in same |
| 05/31/2001 | WO2001037864A1 A novel method of diagnosing, monitoring, staging, imaging and treating cancer |
| 05/31/2001 | WO2001037859A2 Pharmaceutical compositions containing compounds which increase or decrease tmtnf levels |
| 05/31/2001 | WO2001037857A1 Major intrinsic protein (mip)-like polynucleotides, polypeptides, and antibodies |
| 05/31/2001 | WO2001037848A1 Mixture of pomegranate seed oil and juice products |
| 05/31/2001 | WO2001037835A1 Novel compounds |
| 05/31/2001 | WO2001037830A1 Method for increasing the concentration of ascorbic acid in brain tissues of a subject |
| 05/31/2001 | WO2001037823A1 Substituted nitrobenzene derivatives as medicines and other useful uses thereof |
| 05/31/2001 | WO2001037820A2 Ionizable indolinone derivatives and their use as ptk ligands |
| 05/31/2001 | WO2001037819A2 Use of indirubine derivatives for making medicines |
| 05/31/2001 | WO2001037808A1 Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 05/31/2001 | WO2001037780A2 Urotensin-ii analogs |
| 05/31/2001 | WO2001037779A2 A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer |
| 05/31/2001 | WO2001037671A1 Anti-angiogenic cellular agent for cancer therapy |
| 05/31/2001 | WO2001009186A3 Therapeutic compounds comprised of anti-fc receptor binding agents |
| 05/31/2001 | WO2001009103A3 Imidazole antiproliferative agents |
| 05/31/2001 | WO2001005411A8 Compositions addressing inflammation and/or degenerative disorders |
| 05/31/2001 | WO2001002571A3 An interleukin-1 receptor antagonist and uses thereof |
| 05/31/2001 | WO2000073307A3 Substituted 8-phenylxanthines useful as antagonists of a2b adenosine receptors |
| 05/31/2001 | WO2000069472A3 Enzyme-activated anti-tumor prodrug compounds |
| 05/31/2001 | WO2000066593A3 Novel spirocyclic compounds, method for the production thereof and their use for treating hyperproliferative diseases |
| 05/31/2001 | WO2000064414A3 Solid pharmaceutical formulations of acid-sensitive proton-pump blockers |
| 05/31/2001 | WO2000061754A3 Human proteins and polynucleotides encoding them |
| 05/31/2001 | WO2000057864A3 Cyclic glycerophosphates and analogs thereof |
| 05/31/2001 | WO2000056350A3 Methods of use of beta 1-integrin inhibitors |
| 05/31/2001 | WO2000055345A3 Therapy of cancer by insect cells containing recombinant baculovirus encoding genes |
| 05/31/2001 | WO2000045853A3 Treatment of tumors with genetically engineered herpes virus |
| 05/31/2001 | WO2000042071A3 Compounds and methods to inhibit or augment an inflammatory response |
| 05/31/2001 | WO2000010507A3 Use of melanin for inhibition of angiogenesis and macular degeneration |
| 05/31/2001 | WO2000009512A3 Bipyridine manganese complexes |
| 05/31/2001 | US20010002397 24-Hydroxyvitamin D, analogs and uses thereof |
| 05/31/2001 | US20010002393 Administering to a patient suffering from leiomyoma (fibroid)of uterus an effective dose of an agent which specifically inhibit metalloproteinase selected from stromelysin-2, stromelysin-3 and matrilysin |
| 05/31/2001 | DE19956848A1 Curcumin-Formulierungen Curcumin formulations |
| 05/31/2001 | CA2706113A1 Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 05/31/2001 | CA2422429A1 A method of treating a malignancy in a subject and a pharmaceutical composition for use in same |
| 05/31/2001 | CA2395564A1 Novel compounds |
| 05/31/2001 | CA2395049A1 Pyrimidine derivatives as selective inhibitors of cox-2 |